Recent and archived news stories on: biotechnology, pharmaceutical companies, health insurance companies, hospitals, medical devices, medical groups

Local Diagnostic Companies Make Deals to Further Develop Tests to Detect Cancers

Two local diagnostic companies in recent weeks announced deals to further develop tests to detect cancers.

Tease photo

Topography Health Raises $21.5M

Hollywood Hills West-based Topography Health Inc., which has a program to help community physicians set up clinical trials, announced its official launch on Jan. 19 after raising $21.5 million in a Series A funding round.

Tease photo

Capricor Inks Commercialization Deal with Japanese Firm

Beverly Hills-based biotechnology company Capricor Therapeutics Inc. announced on Jan. 25 a major commercialization and distribution deal with a Japanese pharmaceutical company for its drug to treat the rare degenerative genetic disease Duchene muscular dystrophy.

Tease photo

Fulgent Still Riding Covid Testing Wave

Just two years ago, Temple City-based Fulgent Genetics Inc. was a small but promising genetic testing company with $32 million in revenue for all of 2019.

Tease photo

RadNet Bringing AI to Imaging Centers

After taking a hit during the initial Covid-19 lockdown, Sawtelle-based RadNet Inc., the nation’s largest operator of stand-alone diagnostic imaging centers, is revolutionizing the industry through its use of artificial intelligence and joint ventures with hospital networks.

Tease photo

TigerConnect Secures $300M Private Equity Investment

The Santa Monica-based health tech communications platform provider received the investment from a New York-based private equity firm.

Tease photo

Senior Health Services Coordination Firm HeyRenee Raises $8M in Pre-Launch Funding

Santa Monica-based digital health startup SixD Inc., which does business as HeyRenee, announced Jan. 13 that it had closed a second round of seed funding, bringing its total amount raised to $8.2 million as it prepares to launch its senior-oriented service next quarter.

Tease photo

Soon-Shiong Pours Another $300M Into ImmunityBio

After a rough inaugural year as a publicly traded company, has ImmunityBio Inc. finally turned the corner?

Tease photo

Arrowhead Pharmaceuticals Plans $250M Manufacturing Plant in Wisconsin

Pasadena-based Arrowhead Pharmaceuticals Inc. last month announced an investment of up to $250 million for a new drug manufacturing facility outside of California.

Tease photo

Prolacta Bioscience Begins Testing Its Breast Milk-Based Products for Use in Japan

Duarte-based Prolacta Bioscience Inc., which has been fortifying and supplying human breast milk from donors to premature and critically ill infants in hospitals across the United States since 1999, is attempting to go international for the first time.

Tease photo

City of Hope Acquires National Chain of Cancer Treatment Centers

In its largest cancer treatment acquisition to date, City of Hope announced it has agreed to purchase Cancer Treatment Centers of America.

Tease photo

Keck Graduate Institute Receives $1M Gift for Medical School Scholarship Fund

The gift will be used to establish a scholarship fund for a master of science in community medicine degree program within the KGI School of Medicine.

Tease photo

ImmunityBio Strikes Deals in Effort to Speed Development of Covid Vaccine

In recent weeks, Culver City-based ImmunityBio Inc. has struck deals with two companies to gain access to technologies to help speed development of its Covid-19 vaccine candidate.

Tease photo

Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx

Westwood-based Puma Biotechnology Inc. announced Nov. 23 that it has won from U.S. regulators a five-year extension on the patent for its breast cancer therapy Nerlynx.

Tease photo

Son Takes Over From Father as Co-CEO of Apollo Medical Holdings

There’s been a generational leadership change at Alhambra-based Apollo Medical Holdings Inc.